{"id":4170,"date":"2024-02-23T19:35:56","date_gmt":"2024-02-23T19:35:56","guid":{"rendered":"https:\/\/macumira-premium.4ecps.com\/?p=4170"},"modified":"2025-08-20T21:07:50","modified_gmt":"2025-08-20T21:07:50","slug":"macumira-vision-therapy-for-dry-amd-the-perfect-complement-to-other-treatment-modalities","status":"publish","type":"post","link":"https:\/\/macumira.com\/ca\/macumira-vision-therapy-for-dry-amd-the-perfect-complement-to-other-treatment-modalities\/","title":{"rendered":"MacuMira Vision Therapy for dry AMD: The perfect complement to other treatment modalities"},"content":{"rendered":"

While it\u2019s highly effective on its own, MacuMira Vision Therapy is also the perfect complement to other dry AMD treatment components, such as nutraceuticals.<\/p>\n\n\n\n

Understanding AMD and its treatments<\/h2>\n\n\n\n

Age-related macular degeneration (AMD) is an eye disease that generally develops due to aging, genetics and\/or outside factors like smoking. It is one of the leading causes of blindness in adults aged 55 years and older.[1]<\/sup><\/a> There are two types of AMD<\/a>, dry AMD and wet AMD (a more severe form). Dry AMD can progress into wet AMD in about 10-20 per cent of the AMD population.<\/p>\n\n\n\n

Traditionally, therapies for patients with dry AMD \u2014 the most common form of AMD \u2014 have included treatments such as nutraceuticals-based therapies, complement inhibition, gene therapy, visual cycle modulators, neuroprotection, anti-inflammatory therapies, photobiomodulation and prostheses \u2014 most of which are painful and invasive, such as eye surgeries or eye injections.[2]<\/sup><\/a><\/a><\/p>\n\n\n\n